v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 24, 2025
Dec. 19, 2025
Dec. 18, 2025
Jul. 30, 2025
Jul. 29, 2025
Jun. 09, 2025
May 14, 2025
Mar. 24, 2025
Feb. 14, 2025
Feb. 12, 2025
Feb. 11, 2025
Jan. 30, 2025
Dec. 19, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 13, 2024
Cash, FDIC insured amount                           $ 250,000      
Cash equivalents                           0 $ 0    
Amortization expense                           $ 1,122,639 $ 721,533    
Commoon stock par value                           $ 0.0001 $ 0.0001    
Stock issued during the period, shares 1,930,502       198,000 100,000     80,000 100,000              
Common stock issuance   $ 2,499,995 $ 2,499,995         $ 4,750,000           $ 4,625,355 $ 1,328,268    
Sale of stock, price per share   $ 1.295 $ 1.295                            
Net sales revenue percentage             10.00%                    
Gross sales             $ 5,000,000                    
Inventory write-downs                             0 $ 0  
Marketing and advertising expense                           $ 822,860 $ 1,478,663    
Options [Member]                                  
Anti-dilutive securities                           2,156,666 156,667    
Warrant [Member]                                  
Anti-dilutive securities                           2,928,401 940,333    
Derivative [Member]                                  
Anti-dilutive securities                           0 0    
Common Stock [Member]                                  
Commoon stock par value               $ 0.0001                  
Stock issued during the period, shares               1,000,000     140,000     2,877,854 345,000    
Common stock issuance                         $ 1,200,000        
Additional Paid-in Capital [Member] | Revision of Prior Period, Reclassification, Adjustment [Member]                                  
Dividend                           $ 832,109      
Master Distribution Agreement [Member]                                  
Amortization expense                           600,553      
Fair value of distribution rights                           1,362,447      
Impairment charges                           $ 1,239,942      
Master Distribution Agreement [Member] | Propre Energie Inc [Member]                                  
Finite lived intangible assets, estimated useful lives                       3 years          
Common shares issued for consideration                       650,000          
Commoon stock par value                       $ 0.0001          
Fair value of shares issued                       $ 1,963,000          
Recission Agreement [Member] | Navy Wharf Ltd [Member]                                  
Stock redeemed or called during period, shares       1,000,000                          
Sale of stock, price per share       $ 4.75                          
Stock redeemed or called during period, value       $ 4,750,000                          
Minimum [Member]                                  
Property and equipment, estimated useful lives                           3 years      
Maximum [Member]                                  
Property and equipment, estimated useful lives                           5 years      
Patents [Member]                                  
Amortization expense                           $ 1,122,639      
Finite lived amortization thereafter                           $ 8,496,783      
Patents [Member] | Minimum [Member]                                  
Finite lived intangible assets, estimated useful lives                           14 years      
Patents [Member] | Maximum [Member]                                  
Finite lived intangible assets, estimated useful lives                           17 years      
Third Parties [Member]                                  
Non controlling interest ownership percentage                           2.00%      
MangoRx Mexico [Member]                                  
Equity ownership percentage                           98.00%     98.00%
MangoRx UK Limited [Member]                                  
Equity ownership percentage                           100.00%     100.00%